The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Ikorel 20mg Tablets

Sanofi-Aventis Ireland Limited T/A SANOFIPA0540/102/002

Main Information

Trade NameIkorel 20mg Tablets
Active SubstancesNicorandil
Dosage FormTablet
Licence HolderSanofi-Aventis Ireland Limited T/A SANOFI
Licence NumberPA0540/102/002

Group Information

ATC CodeC01DX Other vasodilators used in cardiac diseases
C01DX16 nicorandil


License statusWithdrawn
Withdrawn Date24/08/2023
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back